|
2024
|
Invention
|
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods o... |
|
2023
|
G/S
|
Providing financial information about healthcare insurance plans, patient financial assistance, a... |
|
|
Invention
|
Anti-trem2 antibody and uses thereof. The present invention provides anti-TREM2 antibodies, formu... |
|
|
G/S
|
Providing information about healthcare insurance plans, patient financial assistance, and patient... |
|
2022
|
Invention
|
Heterocyclic compounds as triggering receptor expressed on myeloid cells2 agonists and methods of... |
|
|
Invention
|
Anti-trem2 antibody and uses thereof.
The present invention provides anti-TREM2 antibodies, form... |
|
|
Invention
|
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists. The present ... |
|
|
Invention
|
Trem2 agonist biomarkers and methods of use thereof.
The present invention provides a method of ... |
|
|
Invention
|
Trem2 agonist biomarkers and methods of use thereof. The present invention provides a method of t... |
|
2021
|
Invention
|
Treatment of diseases related to atp-binding cassette transporter 1 dysfunction using trem2 agoni... |
|
|
Invention
|
Treatment of diseases related to colony-stimulating factor 1 receptor dysfunction using trem2 ago... |
|
|
G/S
|
Pharmaceutical research and development in the area of central nervous system disorders with micr... |
|
|
G/S
|
Pharmaceutical research and development; drug development
and discovery services; medical and sc... |
|
|
G/S
|
Pharmaceutical research and development; drug development and discovery services; medical and sci... |
|
|
G/S
|
Pharmaceutical preparations, veterinary preparations. |
|
2020
|
G/S
|
Pharmaceutical research and development; pharmaceutical drug development and drug discovery servi... |
